Palo Verde, CA (PRWEB) September 9, 2005
Dee Coats, the first Californian to receive VesCellÂ stem cell therapy for heart disease is featured in the September 1st issue of the Palo Verde Valley Times. The story, ÂBlythe womanÂs trip to Bangkok repairs damaged heartÂ authored by Marty Bachman can be found on the Palo Verde Valley Times home page.
Coats is quoted as saying, ÂYou feel so much better so quickly, its amazing, I do more and more every day. Now I can walk further than half a block without having to sit down and have a heart attack.Â
Coats further noted that her cardiologist has re-classed her from a Class 3 to a Class 2 cardiac patient and is taking her off three of the medications she had been taking.
VesCellÂ uses a patientÂs own adult stem cells to treat Heart Disease and is a viable alternative for patients who either cannot undergo or choose not to undergo the standard treatment such as Coronary Artery Bypass Grafting (CABG).
VesCellÂ uses adult stem cells harvested from approximately Â½ pint of the patients own blood to treat several heart conditions. Once harvested, the cells are differentiated and expanded in vitro at the TheraVitae Labs in Israel and are ready for implantation in about one week.
TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology called VesCellÂ that is currently being used by hospitals in Thailand to treat patients with heart disease. TheraVitae is based in Bangkok, Thailand, Kiryat Weizmann, Israel, and Hong Kong.